i-Lumen Scientific
PrivateLast Round
Series B
Sep 30, 2025
Est. Valuation
$69.3M
Total Funding Raised
$29.4M
Company Overview
i-Lumen Scientific operates in Healthcare & Life Sciences and is based in Bloomington, Minnesota. Its latest recorded funding round was a Series B round in November 2022.
i-Lumen Scientific is a medical technology company that develops non-invasive transpalpebral microcurrent electrical stimulation technology to treat vision loss caused by dry age-related macular degeneration.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
i-Lumen Scientific Comparables
Compare i-Lumen Scientific with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MacuMira Medical Devices Inc | 87% | |
| Nova Oculus Medical | 86% | |
| SYSTANE | 84% |
For institutional investors. Book with your work email.
i-Lumen Scientific Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 30, 2025 | ||||
| Series B | Nov 15, 2022 | ||||
| Series A Extension | Nov 15, 2022 | ||||
| Convertible Debt | Sep 30, 2021 | ||||
| Series A | Sep 30, 2021 | ||||
Series A | Jul 30, 2020 |
For institutional investors. Book with your work email.
i-Lumen Scientific Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wexford Capital | Series B |
| K2X Capital | Series B |
| MedFocus Funds | Series B |
| Alafi Capital | Series B |
| Santen Ventures | Series B |
| Bios Partners | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 30, 2026
Executing i-LUMEN™ system trial with operations in US and Australia.
- Sep 30, 2025
$18M round led by Alafi Capital and Bios Partners.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventNov 10, 2026
i-LUMEN SCIENTIFIC, Inc. attends the 2026 Clinical Trials at the Summit Retina meeting in Minnesota and announces clinical findings from its i-SIGHT feasibility study on Nov 10th '26.
- attends_eventNov 10, 2026
i-LUMEN SCIENTIFIC, Inc. attends the 2026 Clinical Trials at the Summit Retina meeting in Minnesota on Nov 10th '26, following the presentation of clinical findings from its i-SIGHT feasibility study.
For institutional investors. Book with your work email.
i-Lumen Scientific Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about i-Lumen Scientific's valuation, stock price, and market status.
Is i-Lumen Scientific a public or private company?
i-Lumen Scientific is a private company.
What is the current stock price of i-Lumen Scientific?
i-Lumen Scientific is a private company, so its shares have no public market price. Caplight tracks i-Lumen Scientific's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is i-Lumen Scientific worth (valuation)?
i-Lumen Scientific's valuation is estimated at $69.3M based on funding round data.
Can I buy i-Lumen Scientific stock?
i-Lumen Scientific shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was i-Lumen Scientific's last funding round?
i-Lumen Scientific's most recent funding round was Series B on September 30, 2025.
Who are the main investors in i-Lumen Scientific?
Key investors in i-Lumen Scientific include Alafi Capital, Bios Partners.
Will i-Lumen Scientific IPO soon?
No public IPO plans have been announced for i-Lumen Scientific.
How can I track i-Lumen Scientific secondary market activity?
Caplight tracks bids, offers, and trades in i-Lumen Scientific's shares on secondary markets.